Ardelyx Appoints Rajani Dinavahi, MD, as Chief Medical Officer

Ardelyx has appointed Rajani Dinavahi, MD, as its new Chief Medical Officer. Dinavahi brings over two decades of experience in healthcare and biotechnology, with a track record of advancing programs from early development through Phase 3 and regulatory approval. She joins Ardelyx from Atara Biotherapeutics, where she was Senior Vice President and Chief Medical Officer. As CMO, Dinavahi will be responsible for leading the company's clinical development and medical affairs activities.